| Journal of Clinical Microbiology, Apr. 1997,
p. 1013-1015
0095-1137/97/$04.00+0 Copyright © 1997, American Society for Microbiology |
Vol. 35, No. 4 |
| Emilio Bouza,1 Javier Albadalejo,1 Emilia Cercenado,1 M. Jesús Ruiz Serrano,1 Teresa Vicente,1 and Arturo Ortega2 |
| Servicio de Microbiología, Hospital General Universitario "Gregorio Marañón,"1 and Laboratorio de Micobacterias, Instituto de Salud Carlos III,2 Madrid, Spain |
The number of human samples processed in our mycobacteriology laboratory
ranged from 148 per 1,000 admissions in 1988 to 263 per 1,000 admissions
in 1995 (5.2% were positive). The human immunodeficiency virus (HIV)-positive
population contributed 33.3% of all samples, 43.3% of all isolates, and
36% of all new patients. Given that the ratios of the total number of samples
to the number of Mycobacterium-positive samples were 18.3:1 in HIV-positive
patients and 28:1 in HIV-negative patients, efforts to reduce the laboratory
workload should begin with the HIV-negative population.